title: Choice of antibiotic in nonelective cesarean section.
abstract: The use of antibiotics for prophylaxis against infection among women undergoing nonelective cesarean section has become the standard of care in the United States. Many different antibiotics have been used successfully. Single-dose regimens administered after the cord is clamped have proven just as effective as multiple-dose regimens. Although the most frequently used class of antibiotics is the cephalosporin family, the single best agent has not been determined. This study was a double-blind, randomized trial in which we compared a narrow-spectrum cephalosporin (cefazolin; n = 63) with an expanded-spectrum cephamycin (cefoxitin; n = 66) and with a broad-spectrum cephalosporin (cefotaxime; n = 60) used as a single-dose prophylaxis in patients undergoing a nonelective cesarean section. Of the 194 patients enrolled in the study, 189 were evaluable. There was no significant difference between the groups in mean age, gravidity, parity, duration of labor, duration of ruptured membranes, number of vaginal examinations, or socioeconomic status (socioeconomic status was defined by third-party coverage). There was no significant difference among the antibiotics in the incidence of immediate or delayed postoperative infections. These data indicate that a less expensive, narrow-spectrum cephalosporin is as effective as more expensive, broader-spectrum cephamycins and cephalosporins as prophylaxis for patients undergoing nonelective cesarean section.
authors.affiliation: Department of Obstetrics and Gynecology, School of Medicine, University of Kentucky, Lexington 40536-0084.
authors.forename: W D
authors.initials: WD
authors.lastname: Hager
authors.forename: R P
authors.initials: RP
authors.lastname: Rapp
authors.forename: M
authors.initials: M
authors.lastname: Billeter
authors.forename: B B
authors.initials: BB
authors.lastname: Bradley
mesh_terms: D000328:Adult; D001439:Bacteroides / Q000302:isolation & purification; D002437:Cefazolin / Q000627:therapeutic use*; D002439:Cefotaxime / Q000627:therapeutic use*; D002440:Cefoxitin / Q000627:therapeutic use*; D002585:Cesarean Section; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D011247:Pregnancy; D011292:Premedication; D011446:Prospective Studies; D013530:Surgical Wound Infection / Q000517:prevention & control
chemical_list: D002440:Cefoxitin; D002437:Cefazolin; D002439:Cefotaxime